Emerging biomarkers in the detection, diagnosis and management of cervical dysplasia and carcinoma.

about

Emerging biomarkers in the detection, diagnosis and management of cervical dysplasia and carcinoma.

Item

http://www.wikidata.org/entity/Q53519290

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Emerging biomarkers in the det ...... vical dysplasia and carcinoma.

@en

Emerging biomarkers in the det ...... vical dysplasia and carcinoma.

@nl

type

Item

label

Emerging biomarkers in the det ...... vical dysplasia and carcinoma.

@en

Emerging biomarkers in the det ...... vical dysplasia and carcinoma.

@nl

prefLabel

Emerging biomarkers in the det ...... vical dysplasia and carcinoma.

@en

Emerging biomarkers in the det ...... vical dysplasia and carcinoma.

@nl

P1476

Emerging biomarkers in the det ...... vical dysplasia and carcinoma.

@en

P2093

Jeong-Hoon Bae

http://www.w3.org/2001/XMLSchema#string

Jong-Sup Park

http://www.w3.org/2001/XMLSchema#string

P2860

Measurement of Brn-3a levels in Pap smears provides a novel diagnostic marker for the detection of cervical neoplasia

High-throughput methods of regulatory element discovery

Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix

DNA microarray format for detection and subtyping of human papillomavirus.

comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.

Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics.

Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis.

Immunity to oncogenic human papillomaviruses.

Phases of biomarker development for early detection of cancer.

The cervical cancer epidemic that screening has prevented in the UK.

P304

305-314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17530059.1.3.305

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23489351

http://www.w3.org/2001/XMLSchema#string